GENDICINE Trademark

Trademark Overview

On Sunday, October 22, 2017, a trademark application was filed for GENDICINE with the United States Patent and Trademark Office. The USPTO has given the GENDICINE trademark a serial number of 87655037. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 12, 2019. This trademark is owned by Shenzhen Sibiono GeneTech Co., Ltd.. The GENDICINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Bacteriological research; Biological research; Chemical research; Packaging design; Research and development of new products for others; Scientific research; Technical research in the field of pharmaceutical studies; Conducting clinical trials for others
gendicine

General Information

Serial Number87655037
Word MarkGENDICINE
Filing DateSunday, October 22, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 12, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements

Goods and ServicesBacteriological research; Biological research; Chemical research; Packaging design; Research and development of new products for others; Scientific research; Technical research in the field of pharmaceutical studies; Conducting clinical trials for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 31, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShenzhen Sibiono GeneTech Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressShenzhen 518057
CN
Party NameShenzhen Sibiono GeneTech Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShenzhen 518057
CN

Trademark Events

Event DateEvent Description
Monday, August 12, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 12, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 8, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 5, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 1, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, September 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, September 23, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 23, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 13, 2018WITHDRAWAL OF ATTORNEY GRANTED
Thursday, September 13, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Friday, August 24, 2018NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Friday, August 24, 2018NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Friday, August 24, 2018REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Wednesday, August 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 16, 2018ASSIGNED TO LIE
Thursday, July 26, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 26, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 26, 2018NON-FINAL ACTION E-MAILED
Friday, January 26, 2018NON-FINAL ACTION WRITTEN
Monday, January 22, 2018ASSIGNED TO EXAMINER
Tuesday, October 31, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, October 25, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

gendicine research others pharmaceutical field studies conducting trials clinical technical scientific